JLS is an NY-based venture capital fund formed to invest in the exciting intersection of science, technology and neurology, leveraging the enormous potential of plant-based and psychedelic medicines to heal illness and enhance wellness. They focus on the development of drugs for intractable mental and physical conditions and the enabling technology and tools that can accelerate and enhance the delivery of those therapies.
Location: United States, New York
Employees: 11-50
Founded date: 2019
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 28
| Date | Name | Website | Total Raised | Location |
| 10.01.2024 | Enthea | enthea.com | $4M | United Sta... |
| - | Ceretype N... | ceretype.com | - | United Sta... |
| - | HealthMode | mindmed.co | $154.9M | United Sta... |
| - | AWAKN LIFE... | awaknlifesciences.com | - | United Kin... |
| - | Tabula Ras... | tabularasa.ventures | - | United Sta... |
| - | PAROW ENTH... | parowentheobio.science | - | - |
| - | Lucid News | lucid.news | - | - |
| - | Gwella | gwellamushrooms.com | - | Canada, On... |
| - | MINDLEAP H... | mindleap.health | - | - |
| - | Maya Healt... | mayahealth.com | $4.3M | United Sta... |
Show more
Persons 12
| Date | First Name | Last Name | Title | Location | |||
| - | Michael | Gruber | Advisor | linkedin.c... | - | - | - |
| - | - | - | - | linkedin.c... | - | - | - |
| - | SIMEON | SCHNAPPER | Managing p... | linkedin.c... | - | - | - |
| - | Nick | Gillespie | Advisor | linkedin.c... | - | - | - |
| - | Leonard | Pickard | Advisor | linkedin.c... | - | - | - |
| - | Ethan | Nadelmann | Advisor | linkedin.c... | - | - | - |
| - | David | Hirsch | Advisor | linkedin.c... | - | d***d@comp... | - |
| - | LINDSAY | HOOVER | Managing p... | linkedin.c... | - | - | - |
| - | Andrew | TataRsky | Advisor | linkedin.c... | - | - | - |
| - | JEFFREY | SIEGEL | Partner &a... | linkedin.c... | - | - | - |
Show more
Mentions in press and media 3
| Date | Title | Description |
| 16.03.2023 | Meet the top 14 VCs who've bet the most cash on turning psychedelics into medical treatments | Sean McLintock, Sonia Weiss Pick, Michael Sobeck, and Nikolay Tretiyakov Neo Kuma Ventures, WPSS.bio, Ambria Capital, Leafly Tunnel, Tyler Le/Insider This story is available exclusively to Insider subscribers. Become an Insider and start re... |
| 04.11.2021 | Fluence Raises Investment to Meet Demand for Psychedelic Therapy Training | We look forward to implementing the expansion that this funding will allow and welcoming the next generation of therapists to our field. WOODSTOCK, N.Y. (PRWEB) November 04, 2021 Today, psychedelic therapy training provider Fluence announce... |
| 21.01.2021 | Why Investors Are Bullish About Psychedelics | Mazatec psilocybin mushrooms ready for harvest in their growing tub May 19, 2019 in Denver, ... [+] Colorado. (Photo by Joe Amon/MediaNews Group/The Denver Post via Getty Images)Denver Post via Getty Images |